NT
Nobias Therapeutics develops small molecule therapeutics targeting genetically-defined rare diseases, utilizing extensive genomic and health datasets in collaboration with pediatric academic medical centers. The company focuses on accelerating drug discovery for pediatric indications, with plans to expand into adult and non-rare disease markets.
Updated 4 months ago
Funding
$21.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Nobias Therapeutics develops small molecule therapeutics targeting genetically-defined rare diseases, utilizing extensive genomic and health datasets in collaboration with pediatric academic medical centers. The company focuses on accelerating drug discovery for pediatric indications, with plans to expand into adult and non-rare disease markets.